Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERASIROX vs DEFEROXAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERASIROX vs DEFEROXAMINE: Safety Overview

Metric DEFERASIROX DEFEROXAMINE
Total FAERS Reports 11,322 839
Deaths Reported 2,661 152
Death Rate 23.5% 18.1%
Hospitalizations 4,008 314
Average Patient Age 49.8 yrs 41.9 yrs
% Female Patients 50.1% 59.1%
FDA Approval Date Apr 11, 2025 Approved Prior to Jan 1, 1982
Manufacturer AvKARE Novartis Pharmaceuticals Corporation
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription